// App-Quantinova.ai

: Health-Related Quality of Life and Financial Burden of Ethiopian Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors

Researchers

Presenter

  • Fisihatsion Tadesse

Principal Investigators

  • Amha Gebremedhin

  • Abdulaziz Abubeker

  • Alfonso Piciocchi

  • Marta Cipriani

  • Lalise Gemechu

  • Atalay Mulu

  • Getahun Asres

  • Fabio Efficace

Medical Centers

  • Department of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia

  • Department of Internal Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

  • Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy

Locations

  • Ethiopia

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Observational

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved